1.

Additional file 1 of Imported Hyalomma ticks in the Netherlands 2018–2020 ...

2.

Additional file 1 of Imported Hyalomma ticks in the Netherlands 2018–2020 ...

3.

Additional file 1 of Imported Hyalomma ticks in the Netherlands 2018–2020 ...

1.

Additional file 1: of Third national biobank for population-based seroprevalence studies in the Netherlands, including the Caribbean Netherlands ...

2.

Additional file 1: of Third national biobank for population-based seroprevalence studies in the Netherlands, including the Caribbean Netherlands ...

3.

Additional file 1: of Third national biobank for population-based seroprevalence studies in the Netherlands, including the Caribbean Netherlands ...

1.

Relations between air pollution and vascular development in 5-year old children: a cross-sectional study in the Netherlands ...

2.

Relations between air pollution and vascular development in 5-year old children: a cross-sectional study in the Netherlands ...

3.

Relations between air pollution and vascular development in 5-year old children: a cross-sectional study in the Netherlands ...

1.

Mobility assessment of a rural population in the Netherlands using GPS measurements ...

2.

Mobility assessment of a rural population in the Netherlands using GPS measurements ...

3.

Mobility assessment of a rural population in the Netherlands using GPS measurements ...

1.

Imported Hyalomma ticks in the Netherlands 2018–2020 ...

2.

Imported Hyalomma ticks in the Netherlands 2018–2020 ...

3.

Imported Hyalomma ticks in the Netherlands 2018–2020 ...

1.

Study design and characteristics of the Luxembourg European Health Examination Survey (EHES-LUX) ...

2.

Study design and characteristics of the Luxembourg European Health Examination Survey (EHES-LUX) ...

3.

Study design and characteristics of the Luxembourg European Health Examination Survey (EHES-LUX) ...

1.

Additional file 1 of Incorporating ‘reason for use’ into the prescribing process of medication: a survey on the opinion of patients in Flanders, Belgium ...

2.

Additional file 1 of Incorporating ‘reason for use’ into the prescribing process of medication: a survey on the opinion of patients in Flanders, Belgium ...

3.

Additional file 1 of Incorporating ‘reason for use’ into the prescribing process of medication: a survey on the opinion of patients in Flanders, Belgium ...

4.

Additional file 1 of Incorporating ‘reason for use’ into the prescribing process of medication: a survey on the opinion of patients in Flanders, Belgium ...

5.

Additional file 1 of Incorporating ‘reason for use’ into the prescribing process of medication: a survey on the opinion of patients in Flanders, Belgium ...

6.

Additional file 1 of Incorporating ‘reason for use’ into the prescribing process of medication: a survey on the opinion of patients in Flanders, Belgium ...

7.

Additional file 1 of Incorporating ‘reason for use’ into the prescribing process of medication: a survey on the opinion of patients in Flanders, Belgium ...

1.

Incorporating ‘reason for use’ into the prescribing process of medication: a survey on the opinion of patients in Flanders, Belgium ...

2.

Incorporating ‘reason for use’ into the prescribing process of medication: a survey on the opinion of patients in Flanders, Belgium ...

3.

Incorporating ‘reason for use’ into the prescribing process of medication: a survey on the opinion of patients in Flanders, Belgium ...

4.

Incorporating ‘reason for use’ into the prescribing process of medication: a survey on the opinion of patients in Flanders, Belgium ...

5.

Incorporating ‘reason for use’ into the prescribing process of medication: a survey on the opinion of patients in Flanders, Belgium ...

6.

Incorporating ‘reason for use’ into the prescribing process of medication: a survey on the opinion of patients in Flanders, Belgium ...

7.

Incorporating ‘reason for use’ into the prescribing process of medication: a survey on the opinion of patients in Flanders, Belgium ...

1.

Additional file 1 of The clinical manifestation and the influence of age and comorbidities on long-term chikungunya disease and health-related quality of life: a 60-month prospecti...

2.

Additional file 1 of The clinical manifestation and the influence of age and comorbidities on long-term chikungunya disease and health-related quality of life: a 60-month prospecti...

3.

Additional file 1 of The clinical manifestation and the influence of age and comorbidities on long-term chikungunya disease and health-related quality of life: a 60-month prospecti...

1.

Additional file 2 of The clinical manifestation and the influence of age and comorbidities on long-term chikungunya disease and health-related quality of life: a 60-month prospecti...

2.

Additional file 2 of The clinical manifestation and the influence of age and comorbidities on long-term chikungunya disease and health-related quality of life: a 60-month prospecti...

3.

Additional file 2 of The clinical manifestation and the influence of age and comorbidities on long-term chikungunya disease and health-related quality of life: a 60-month prospecti...